Field cancerization: Looking to the future

Affiliations

¹ Division of Dermatology, Department of Internal Medicine, The University of Texas at Austin Dell Medical School, Austin, Texas.
² Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Rakuten Medical, Inc., San Diego, California.
⁴ Division of Dermatology, Department of Internal Medicine, The University of Texas at Austin Dell Medical School, Austin, Texas. Electronic address: Anokhi.Jambusaria@austin.utexas.edu.

Comment

Tyler J Willenbrink et al. J Am Acad Dermatol. 2021 Jul.

. 2021 Jul;85(1):e43-e44.

doi: 10.1016/j.jaad.2021.02.077. Epub 2021 Mar 6.

¹ Division of Dermatology, Department of Internal Medicine, The University of Texas at Austin Dell Medical School, Austin, Texas.
² Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Rakuten Medical, Inc., San Diego, California.
⁴ Division of Dermatology, Department of Internal Medicine, The University of Texas at Austin Dell Medical School, Austin, Texas. Electronic address: Anokhi.Jambusaria@austin.utexas.edu.

No abstract available

Conflict of interest statement

Conflicts of interest None disclosed.

Field cancerization: Definition, epidemiology, risk factors, and outcomes.
Willenbrink TJ, Ruiz ES, Cornejo CM, Schmults CD, Arron ST, Jambusaria-Pahlajani A. Willenbrink TJ, et al. J Am Acad Dermatol. 2020 Sep;83(3):709-717. doi: 10.1016/j.jaad.2020.03.126. Epub 2020 May 7. J Am Acad Dermatol. 2020. PMID: 32387665 Review.
Field cancerization in the skin: Past errors repeated.
Morton S, Muir J. Morton S, et al. J Am Acad Dermatol. 2021 Jul;85(1):e41. doi: 10.1016/j.jaad.2020.12.094. Epub 2021 Mar 9. J Am Acad Dermatol. 2021. PMID: 33711362 No abstract available.